Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junya Yan

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Biology Direct|June 13, 2026
USP20 as a key regulator of immunosuppression and a novel predictor of poor prognosis in lung adenocarcinomaLonghao Wang, Danni Qiao, Ruixue Gu, et al.
Oncology Letters|September 21, 2017
Mutations in BRAF codons 594 and 596 predict good prognosis in melanomaXiaowen Wu, Junya Yan, Jie Dai, et al.
Journal of Hematology & Oncology|January 5, 2018
Anti-GD2/4-1BB chimeric antigen receptor T cell therapy for the treatment of Chinese melanoma patientsJiayi Yu, Xiaowen Wu, Junya Yan, et al.
Cancer Biology & Therapy|May 1, 2018
PI3K/AKT/mTOR pathway inhibitors inhibit the growth of melanoma cells with mTOR H2189Y mutations in vitroXiaowen Wu, Jiayi Yu, Junya Yan, et al.
Human Pathology|February 17, 2018
Gene expression screening identifies CDCA5 as a potential therapeutic target in acral melanomaTianxiao Xu, Meng Ma, Jie Dai, et al.
Journal of Cancer|April 21, 2018
Increased <i>AURKA</i> Gene Copy Number Correlates with Poor Prognosis and Predicts the Efficacy of High-dose Interferon Therapy in Acral MelanomaJunya Yan, Jiayi Yu, Xiaowen Wu, et al.
Cancer Science|April 17, 2018
High G2 and S-phase expressed 1 expression promotes acral melanoma progression and correlates with poor clinical prognosisTianxiao Xu, Meng Ma, Zhihong Chi, et al.
Oncology Letters|February 14, 2018
Clinical significance of BRAF<sup>V600E</sup> mutation in circulating tumor DNA in Chinese patients with melanomaHuan Tang, Yan Kong, Lu Si, et al.
Journal of Cancer Research and Clinical Oncology|November 30, 2017
Analysis of TSC1 mutation spectrum in mucosal melanomaMeng Ma, Jie Dai, Tianxiao Xu, et al.
Melanoma Research|August 8, 2018
Establishment and characterization of melanoma patient-derived xenograft models for preclinical evaluation of novel therapeuticsJunya Yan, Xiaowen Wu, Jiayi Yu, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Biology Direct|June 13, 2026
USP20 as a key regulator of immunosuppression and a novel predictor of poor prognosis in lung adenocarcinomaLonghao Wang, Danni Qiao, Ruixue Gu, et al.
Oncology Letters|September 21, 2017
Mutations in BRAF codons 594 and 596 predict good prognosis in melanomaXiaowen Wu, Junya Yan, Jie Dai, et al.
Journal of Hematology & Oncology|January 5, 2018
Anti-GD2/4-1BB chimeric antigen receptor T cell therapy for the treatment of Chinese melanoma patientsJiayi Yu, Xiaowen Wu, Junya Yan, et al.
Cancer Biology & Therapy|May 1, 2018
PI3K/AKT/mTOR pathway inhibitors inhibit the growth of melanoma cells with mTOR H2189Y mutations in vitroXiaowen Wu, Jiayi Yu, Junya Yan, et al.
Human Pathology|February 17, 2018
Gene expression screening identifies CDCA5 as a potential therapeutic target in acral melanomaTianxiao Xu, Meng Ma, Jie Dai, et al.
Journal of Cancer|April 21, 2018
Increased <i>AURKA</i> Gene Copy Number Correlates with Poor Prognosis and Predicts the Efficacy of High-dose Interferon Therapy in Acral MelanomaJunya Yan, Jiayi Yu, Xiaowen Wu, et al.
Cancer Science|April 17, 2018
High G2 and S-phase expressed 1 expression promotes acral melanoma progression and correlates with poor clinical prognosisTianxiao Xu, Meng Ma, Zhihong Chi, et al.
Oncology Letters|February 14, 2018
Clinical significance of BRAF<sup>V600E</sup> mutation in circulating tumor DNA in Chinese patients with melanomaHuan Tang, Yan Kong, Lu Si, et al.
Journal of Cancer Research and Clinical Oncology|November 30, 2017
Analysis of TSC1 mutation spectrum in mucosal melanomaMeng Ma, Jie Dai, Tianxiao Xu, et al.
Melanoma Research|August 8, 2018
Establishment and characterization of melanoma patient-derived xenograft models for preclinical evaluation of novel therapeuticsJunya Yan, Xiaowen Wu, Jiayi Yu, et al.
Pageof 4